Murray Christopher K.'s Form 4 filing
Blueprint Medicines Corp (BPMC) · filed Mar 8, 2022
- Accession no.
- 0001415889-22-002737
- Filed
- Mar 8, 2022
- Trade date
- Mar 3-7, 2022
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $92.5K. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Murray Christopher K.CIK 0001718648 | Officer (SVP, TECHNICAL OPERATIONS) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2022 | Common Stock | SSaleDisposed | −1,066 | $60.27 | −$64,247.82 | 24,322 | Direct | |
| Mar 7, 2022 | Common Stock | SSaleDisposed | −502 | $56.19 | −$28,207.38 | 23,820 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.